175 related articles for article (PubMed ID: 30136907)
1. An overview of properties of Amphora (Acidform) contraceptive vaginal gel.
Nelson AL
Expert Opin Drug Saf; 2018 Sep; 17(9):935-943. PubMed ID: 30136907
[TBL] [Abstract][Full Text] [Related]
2. Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.
Amaral E; Faúndes A; Zaneveld L; Waller D; Garg S
Contraception; 1999 Dec; 60(6):361-6. PubMed ID: 10715372
[TBL] [Abstract][Full Text] [Related]
3. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.
Barnhart KT; Rosenberg MJ; MacKay HT; Blithe DL; Higgins J; Walsh T; Wan L; Thomas M; Creinin MD; Westhoff C; Schlaff W; Archer DF; Ayers C; Kaunitz A; Das S; Moench TR
Obstet Gynecol; 2007 Sep; 110(3):577-86. PubMed ID: 17766603
[TBL] [Abstract][Full Text] [Related]
4. Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive.
Keller MJ; Carpenter CA; Lo Y; Einstein MH; Liu C; Fredricks DN; Herold BC
PLoS One; 2012; 7(10):e46901. PubMed ID: 23056520
[TBL] [Abstract][Full Text] [Related]
5. ACIDFORM: a review of the evidence.
Bayer LL; Jensen JT
Contraception; 2014 Jul; 90(1):11-8. PubMed ID: 24565736
[TBL] [Abstract][Full Text] [Related]
6. Microbicidal spermicide or spermicidal microbicide?
Gupta G
Eur J Contracept Reprod Health Care; 2005 Dec; 10(4):212-8. PubMed ID: 16448947
[TBL] [Abstract][Full Text] [Related]
7. GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion.
D'Cruz OJ; Yiv SH; Uckun FM
AAPS PharmSciTech; 2001 Apr; 2(2):E5. PubMed ID: 14727880
[TBL] [Abstract][Full Text] [Related]
8. Clinical development of microbicides for the prevention of HIV infection.
D'Cruz OJ; Uckun FM
Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
[TBL] [Abstract][Full Text] [Related]
9. Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM).
Garg S; Anderson RA; Chany CJ; Waller DP; Diao XH; Vermani K; Zaneveld LJ
Contraception; 2001 Jul; 64(1):67-75. PubMed ID: 11535216
[TBL] [Abstract][Full Text] [Related]
10. Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product.
Amaral E; Perdigão A; Souza MH; Mauck C; Waller D; Zaneveld L; Faúndes A
Contraception; 2004 Dec; 70(6):492-7. PubMed ID: 15541412
[TBL] [Abstract][Full Text] [Related]
11. Vaginal contraceptives. Effective protection from sexually transmitted diseases for women?
North BB
J Reprod Med; 1988 Mar; 33(3):307-11. PubMed ID: 2834553
[TBL] [Abstract][Full Text] [Related]
12. Contraceptive efficacy and safety of HerbOshield™ vaginal gel in rats.
Singh KK; Parmar S; Tatke PA
Contraception; 2012 Jan; 85(1):122-7. PubMed ID: 22067802
[TBL] [Abstract][Full Text] [Related]
13. Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product.
Amaral E; Perdigao A; Souza MH; Mauck C; Waller D; Zaneveld L; Faundes A
Contraception; 2006 May; 73(5):542-7. PubMed ID: 16627043
[TBL] [Abstract][Full Text] [Related]
14. Spermicides, HIV, and the vaginal sponge.
Stone KM; Peterson HB
JAMA; 1992 Jul 22-29; 268(4):521-3. PubMed ID: 1320135
[No Abstract] [Full Text] [Related]
15. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.
Stafford MK; Ward H; Flanagan A; Rosenstein IJ; Taylor-Robinson D; Smith JR; Weber J; Kitchen VS
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):327-31. PubMed ID: 9525433
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of the amount of nonoxynol-9 remaining in the vagina up to 4 h after insertion of a vaginal contraceptive film (VCF) containing 70 mg nonoxynol-9.
Mauck CK; Allen S; Baker JM; Barr SP; Abercrombie T; Archer DF
Contraception; 1997 Aug; 56(2):103-10. PubMed ID: 9315419
[TBL] [Abstract][Full Text] [Related]
17. Mucosal integrity and inflammatory markers in the female lower genital tract as potential screening tools for vaginal microbicides.
Su HI; Schreiber CA; Fay C; Parry S; Elovitz MA; Zhang J; Shaunik A; Barnhart K
Contraception; 2011 Nov; 84(5):525-32. PubMed ID: 22018129
[TBL] [Abstract][Full Text] [Related]
18. Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations.
Harwood B; Meyn LA; Ballagh SA; Raymond EG; Archer DF; Creinin MD
Am J Obstet Gynecol; 2008 Jan; 198(1):32.e1-7. PubMed ID: 18166301
[TBL] [Abstract][Full Text] [Related]
19. Physiological aspects of vaginal contraception.
Bernstein GS
Contraception; 1974 Apr; 9(4):333-45. PubMed ID: 4613535
[TBL] [Abstract][Full Text] [Related]
20. New spermicide: FHI developing propranolol.
Netw Res Triangle Park N C; 1986; 7(2):2-3. PubMed ID: 12340619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
